To Imaging and Beyond...
Imaging Beyond goes further than conventional methods—fusing AI and radiogenomics to transform how we see, understand, and act on disease. We're not just keeping pace with the future of imaging. We're shaping it.
Welcome to Imaging Beyond.
Future of Medical Imaging
Report
Meet GLIOMA ai
Glioma AI predicts the genotypes of glioma based on MRI images. It is designed to work with experts to provide a hybrid diagnosis.
This is especially useful for patients who can not undergo a biopsy because of co-morbidities or other reasons.
-
40%
Reduction in the Neuro-oncology MDT workload.
-
90%
Early identification of molecular glioblastomas.

Molecular glioblastomas
Some aggressive brain tumours can look harmless on routine scans and even under the microscope. These are called molecular glioblastomas, and they can only be identified through advanced genetic testing. Recent studies suggest that up to 24% of glioblastomas fall into this category—but the real number is likely higher, since many hospitals only run these genetic tests when there’s already a strong suspicion.
Disclaimer
Glioma AI is not inteded to be used as stand alone tool for diagnosis or treatment planning
Read about our net zero goals
Contact us
Discover the Future of Medical Imaging